Both in Pharmaceuticals
Enanta Pharmaceuticals vs Emergent Biosolutions
Over the past year ENTA returned −0.8% and EBS returned −42.3%; their daily moves had a correlation of 0.24.
ENTA −0.8% EBS −42.3%Growth of $1, one year, split-adjusted
| Metric | ENTA | EBS |
|---|---|---|
| Price | $10.73 | $6.06 |
| Market cap | $312.5M | $310.5M |
| Today | +3.47% | −3.12% |
| 1 month | −11.8% | −12.9% |
| 6 months | −29.6% | −33.5% |
| Year to date | −32.0% | −51.0% |
| 1 year | −0.8% | −42.3% |
| Revenue growth (YoY) | −21.6% | −52.4% |
| Gross margin | 100.0% | 26.5% |
| Net margin | −135.8% | −29.7% |
| P/E (TTM) | — | — |
| Price / sales | 4.8× | 0.5× |
| Net cash | $189.5M | -$332.0M |
| Dividend yield | — | — |
| Volatility (60d) | 46.0% | 64.0% |
| Short % of float | 8.2% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).